Dr. Gregory James Kato, MD

  • Bethesda, MD
  • Pediatric hematology and oncology physician
NPI1578504767
Medicare services, 2019
51
Part D claims, 2019
209
Publications
123
Clinical trials
1
Industry payments
$37,537
Practice address
10 Center Dr, Bethesda, MD 20892-0001
Practice phone
Call (301) 451-8497
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Find Dr. Kato's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Gregory James Kato is a pediatric hematology and oncology physician in Bethesda, Maryland

Dr. Kato practices in Bethesda, Maryland.

Dr. Kato's NPI, 1578504767, was assigned on June 9, 2006. Dr. Kato holds Maryland license D36817.

NPI and contact details
NPI enumeration date
June 9, 2006
NPI status
Active
Practice phone
(301) 451-8497
Professional email
Get email
Personal email
Get email
Mobile number
Get number

Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data

Dr. Gregory James Kato's practice address is in Bethesda, Maryland

Dr. Kato's practice address in the NPI Registry is 10 Center Dr, Bethesda, MD 20892-0001. The practice phone is (301) 451-8497.

  • NPI Registry address
    10 Center Dr, Bethesda, MD 20892-0001Phone(301) 451-8497

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dmand AI tracks the EHR system at Dr. Gregory James Kato's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kato practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Dr. Kato's practiceAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Kato practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Gregory James Kato is one of 62 pediatric hematologys and oncology physicians in Maryland

Pediatric hematology-oncology is Dr. Kato's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dr. Kato is licensed in Maryland.

Specialties and state licenses

  • Pediatric hematology and oncology, MarylandPrimaryLicense D36817 · taxonomy 2080P0207X

Pediatric hematologys and oncology physicians near Dr. Kato

Counts of pediatric hematologys and oncology physicians with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Gregory James Kato billed Medicare for 51 services in 2019

CMS data shows 51 Medicare services from Dr. Kato across 2 procedure codes in 2019. Medicare paid $4,644 for them. Every service was in a facility, such as a hospital, rather than an office.

Medicare services, 201951
Paid by Medicare$4,644
Procedure codes2

Dr. Kato's Medicare services by type, 2018 to 2019

  • 2018
  • 2019
Office and hospital visits
2018: 742019: 5131%

Dr. Kato's most billed Medicare procedure codes, 2019

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Kato

Need commercial claims for Dr. Kato?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Kato and other pediatric hematologys and oncology physicians in Maryland.

Book a meeting

Source: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data

Dr. Gregory James Kato wrote 209 Medicare Part D claims in 2019

In 2019, Dr. Kato wrote 209 Medicare Part D claims. They cover 10 drugs, with $15,761 in total drug cost. In 2018, CMS named 300 claims across 12 drugs.

Part D claims, 2019209
Drugs named by CMS10
Total drug cost$15,761

Dr. Kato's most prescribed drugs by claims, 2019

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2018 to 2019

  • 2018
  • 2019
Claims for drugs CMS names
2018: 3002019: 20930%

Drugs named by CMS: 10 in 2019, 12 in 2018.

See all prescribing by Dr. Kato

Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026

For MedTech and pharma teams

Find pediatric hematologys and oncology physicians like Dr. Kato by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Gregory James Kato has 123 publications on record

Dmand AI links 123 papers to Dr. Kato, published from 2005 to 2025. 2019 was the busiest year, with 7. The most frequent topics are Anemia, Sickle Cell, Hypertension, Pulmonary and Hemolysis. Dr. Kato has published most often in Am J Hematol. Dr. Kato's most frequent co-authors are Mark T. Gladwin, Caterina P. Minniti, MD and Victor R. Gordeuk, MD.

Papers123
Years published2005 to 2025

Dr. Kato's papers by year, 2016 to 2025

Topics Dr. Kato writes about most

  • Anemia, Sickle Cell
  • Hypertension, Pulmonary
  • Hemolysis
  • Erythrocytes
  • Hemoglobin, Sickle
  • Tricuspid Valve Insufficiency
  • Hydroxyurea
  • Hemoglobins

Dr. Kato's most frequent co-authors

Recent publications by Dr. Kato

See all 123 publications and co-authors

See who Dr. Kato researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Kato works with, so you can find a warm path to the right pediatric hematologys and oncology physicians.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Gregory James Kato has worked on 1 clinical trial

Dmand AI links Dr. Kato to 1 clinical trial. Conditions studied include Anemia, Sickle Cell and Anemia, Hemolytic, Congenital.

Conditions in Dr. Kato's trials

  • Anemia, Sickle Cell
  • Anemia, Hemolytic, Congenital

Investigators on the most trials with Dr. Kato

Recent clinical trials with Dr. Kato

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Gregory James Kato received $37,537 in industry payments from 2017 to 2019

CMS Open Payments shows 57 general payments to Dr. Kato from 4 drug and device companies from 2017 to 2019. Consulting fees make up the largest share, 62% of the total. Novartis Pharmaceuticals Corporation paid the most, $28,831.

General payments to Dr. Kato by program year, 2017 to 2019

General payments to Dr. Kato by kind, 2017 to 2019

$37.5Kin total
  • Consulting fees$23,34862%
  • Travel and lodging$7,83021%
  • Speaker and faculty fees$4,75013%
  • Food and beverage$1,6094%

Companies that paid Dr. Kato the most, 2017 to 2019

Share is of all general payments to this clinician.

See all payments to Dr. Kato

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Gregory James Kato's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Gregory James Kato

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Gregory James Kato's NPI number?

Dr. Gregory James Kato's NPI number is 1578504767. It was assigned on June 9, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Gregory James Kato?

Dr. Gregory James Kato is a pediatric hematology and oncology physician in Bethesda, Maryland. The primary specialty in the NPI Registry is Pediatric Hematology & Oncology Physician (taxonomy code 2080P0207X).

Where does Dr. Gregory James Kato practice?

Dr. Kato practices at 10 Center Dr, Bethesda, MD 20892-0001.

What is Dr. Gregory James Kato's office phone number?

The practice phone on file for Dr. Kato is (301) 451-8497.

What is Dr. Gregory James Kato's medical license number?

Dr. Kato holds Maryland license D36817.

Does Dr. Gregory James Kato accept Medicare?

Yes. CMS data shows Dr. Kato billed Medicare for 51 services in 2019.

What services does Dr. Gregory James Kato bill to Medicare?

In 2019, Dr. Kato's most billed Medicare services were hospital inpatient care (99222) and hospital inpatient care (99232).

What drugs does Dr. Gregory James Kato prescribe most?

In 2019 Medicare Part D data, Dr. Kato's most prescribed drugs by claims were Oxycodone HCl, Hydroxyurea and Morphine Sulfate ER.

Has Dr. Gregory James Kato received payments from drug or device companies?

CMS Open Payments shows $37,537 in general payments to Dr. Kato from 4 companies from 2017 to 2019. The largest total came from Novartis Pharmaceuticals Corporation.

How long has Dr. Gregory James Kato been practicing?

Dr. Kato's NPI was assigned in 2006.

Does Dr. Gregory James Kato do research?

Dmand AI links 123 publications to Dr. Kato, published from 2005 to 2025. Dr. Kato has worked on 1 clinical trial.

Who does Dr. Gregory James Kato publish with?

Dr. Kato's most frequent co-authors are Mark T. Gladwin (42 shared papers), Caterina P. Minniti, MD (29 shared papers) and Victor R. Gordeuk, MD (26 shared papers).

Selling to pediatric hematology-oncology practices?

See pediatric hematologys and oncology physicians in Maryland by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)